There is a 58 % chance of phase 3 trials succeeding , this puts the odds well in MSbs favour for a successful outcome.The chances of all three trials failing would be a very low percentage and if ,as is probable just one succeeds, it would justify a far higher price than present. Moreover , chances of NDA approval (Ryoncil) are at 85 %. Weighing all this together , I am very comfortable in holding MSB shares which still look to be trading at a sizeable discount given the probability factors stated above.Add in the expected bump from Asx 200 inclusion as a bonus!!
MSB Trading - 2020, page-12907
-
- There are more pages in this discussion • 10,254 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |